Quercetin alleviates hypercholesterolemic diet induced inflammation during progression and regression of atherosclerosis in rabbits

Nutrition

Volumn 29, Issue 1, 2013, Pages 219-229

  Bhaskar, Shobha ^a   Kumar, Kavitha S ^a   Krishnan, Kripa ^a   Antony, Helen ^a  

^a UNIVERSITY OF KERALA   (India)

Author keywords

Atherosclerosis progression and regression; Flavonoid; Inflammation; Quercetin

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; C REACTIVE PROTEIN; LIPOXYGENASE; MYELOPEROXIDASE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE; QUERCETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AORTA INTIMA; ARTICLE; ATHEROSCLEROSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; EXPERIMENTAL RABBIT; FEMALE; HISTOPATHOLOGY; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; TREATMENT DURATION;

ANIMALS; AORTA; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CELLS, CULTURED; CHOLESTEROL, DIETARY; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPIDS; LIPOPROTEINS, LDL; LIPOXYGENASES; NITRIC OXIDE SYNTHASE; PEROXIDASE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; QUERCETIN; RABBITS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 84870817957     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.01.019     Document Type: Article

References (46)

1. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
2. Hansson G. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
3. Skalen K., Gustafsson M., Rydberg E.K., Hulten L.M., Wiklund O., Innerarity T.L., et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 2002, 417:750-754.
4. Leitinger N. Oxidized phospholipids as modulators of inflammation in atherosclerosis. Curr Opin Lipidol 2003, 14:421-430.
5. Burleigh M.E., Babaev V.R., Oates J.A., Harris R.C., Gautam S., Reindeau D., et al. Cyclooxygenase-2 promotes early atherosclerosis lesion in LDL receptor-deficient mice. Circulation 2002, 105:1816-1823.
6. Galkina E., Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 2009, 27:165-197.
7. Hansson G.K. Atherosclerosis-an immune disease. The Anitschkov Lecture 2007. Atherosclerosis 2009, 202:2-10.
8. Bazzano L.A., Serdula M.K., Liu S. Dietary intake of fruits and vegetables and risk of cardiovascular disease. Curr Atheroscler Rep 2003, 5:492-499.
9. Hertog M.G., Feskens E.J., Hollman P.C., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993, 342:1007-1011.
10. Holt E.M., Steffen L.M., Moran A., Basu S., Steinberger J., Ross J.A., et al. Fruit and vegetable consumption and its relation to markers of inflammation and oxidative stress in adolescents. Am Diet Assoc 2009, 109:414-421.
11. Gerritsen M.E., Carley W.W., Ranges G.E., Shen C.P., Phan S.A., Ligon G.F., Perry C.A. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am J Pathol 1995, 147:278-292.
12. Hirotsugu K., Sashwati R., Chandan K.S., Hao G.N., Lester P. Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway. Am J Physiol Cell Physiol 1999, 277:C403-C411.
13. Bhaskar S., Shalini V., Helen A. Quercetin regulates oxidized LDL induced inflammatory changes in human PBMCs by modulating the TLR-NF-κB signaling pathway. Immunobiology 2011, 216:367-373.
14. Juzwiak S., Wojcicki J., Mokrzycki K., Marchlewicz M., Bialecka M., Rozewicka L.W., et al. Effect of quercetin on experimental hyperlipidemia and atherosclerosis in rabbits. Pharmacol Rep 2005, 57:604-609.
15. Huch H.Y., Pearce S.F., Tersner J.M., Schindler I.L., Silverstein R.L. Regulated expression of CD36 in foam cell formation. Blood 1996, 87:2020-2025.
16. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoprotein in human serum. J Clin Invest 1995, 34:1345-1353.
17. Thao N.K., Ziad A.M., Sarsat V.W., Canteloup S., Latscha B.D. Oxidized low density lipoprotein induces macrophage respiratory burst via its protein moiety: a novel pathway in atherogenesis. Biochem Biophys Res Commun 1999, 263:804-809.
18. Boban P.T., Nambisan B., Sudhakaran P.R. Dietary mucilage promotes regression of atheromatous lesion in hypercholesterolemic rabbits. Phytother Res 2009, 23:725-730.
19. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
20. Axelrod B., Cheesebrough T.M., Laakso S. Lipoxygenase from soyabean. Methods Enzymol 1981, 71:441-445.
21. Shimizu T., Kondo K., Hayaishi O. Role of prostaglandin endoperoxidases in the serum thiobarbituric acid reaction. Arch Biochem Biophys 1984, 206:271-276.
22. Salter M., Knowles R.G. Assay of NOS activity by the measurements of conversion of oxyhemoglobin to methemoglobin by NO. Methods in molecular biology nitric oxide protocol 1997, Volume 100:61-65. Humana Press, Totowa, NJ.
23. Bradley P.P., Priebat D.A., Christensen R.D., Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982, 78:206-209.
24. Lowry O.H., Roseburgh N.J., Farr A.L., Randall R.J. Protein measurement with Folin phenol reagent. J Biol Chem 1951, 193:265-275.
25. Knekt P., Jarvinen R., Reunanen A., Maatela J. Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch Intern Med 1995, 155:381-386.
26. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
27. Weber C., Zernecke A., Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 2008, 8:802-815.
28. Hansson G.K., Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006, 6:508-519.
29. Ishikawa Y., Sugiyama H., Stylianou E., Kitamura M. Bioflavonoid quercetin inhibits interleukin-1 induced transcriptional expression of monocyte chemoattractant protein-1 in glomerular cells via suppression of nuclear factor-κB. J Am Soc Nephrol 1999, 10:2290-2296.
30. Csokay B., Prajda N., Weber G., Olah E. Molecular mechanisms in the antiproliferative action of quercetin. Life Sci 1997, 60:2157-2163.
31. Landolfi R., Mower R.L., Steiner M. Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Biochem Pharmacol 1984, 33:1525-1530.
32. Hudson N., Balsitis M., Everitt S., Hawkey C.J. Enhanced gastric mucosal leukotriene B4 synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 1993, 34:742-747.
33. Leach M., Hamilton L.C., Olbrich A., Wray G.M., Thiemermann C. Effects of inhibitors of the activity of cyclo-oxygenase-2 on the hypotension and multiple organ dysfunction caused by endotoxin: a comparison with dexamethasone. Br J Pharmacol 1998, 124:586-592.
34. Galati G., Moridani M.Y., Chan T.S., O'Brein P.J. Peroxidative metabolism of apigenin and naringenin versus luteolin and quercetin: glutathione oxidation and conjugation. Free Radic Biol Med 2001, 30:370-382.
35. Willerson J.T., Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 2004, 109. 112-10.
36. Singh U., Tabibian J., Venugopal S.K., Devaraj S., Jialal I. Development of an in vitro screening assay to test the antiinflammatory properties of dietary supplements and pharmacologic agents. Clin Chem 2005, 51:2252-2256.
37. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., Lipsky P.E. Cyclooxygenase in biology and disease. FASEB J 1998, 12:1063-1073.
38. Radmark O., Samuelsson B. 5-Lipoxygenase: regulation and possible involvement in atherosclerosis. Prostaglandins Other Lipid Mediat 2007, 83:162-174.
39. Kayama Y., Minamino T., Toko H., Sakamoto M., Shimizu I., Takahashi H., et al. Cardiac 12/15 lipoxygenase-induced inflammation is involved in heart failure. J Exp Med 2008, 206:1565-1574.
40. Santangelo C., Varì R., Scazzocchio B., Benedetto R.D., Filesi C., Masella R. Polyphenols, intracellular signaling and inflammation. An Ist Super Sanita 2007, 43:394-405.
41. Kim R.A., Cho J.Y., Zuo Y., Choi J.S., Chung H.Y. Flavonoids differentially modulate nitric oxide production pathways in lipopolysaccharide-activated RAW264.7 cells. Arch Pharm Res 2005, 28:297-304.
42. Aktan F., Henness S., Roufogalis B.D., Ammit A.J. Gypenosides derived from Gynostemma pentaphyllum suppress NO synthesis in murine macrophages by inhibiting iNOS enzymatic activity and attenuating NF-κB-mediated iNOS protein expression. Nitric Oxide 2003, 8:235-242.
43. Bogdan C. Nitric oxide and the immune response. Nat Immunol 2001, 2:907-916.
44. Florez S.M., Fernandex B.G., Campos S.S., Gallego J.G., Tunon M.J. Quercetin attenuates nuclear factor-κB activation and nitric oxide production in interleukin-1β-activated rat hepatocytes. J. Nutr 2005, 135:1359-1365.
45. Nicholls S.J., Hazen S.L. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 2005, 25:1102-1111.
46. Nabata A., Kuroki M., Ueba H., Hashimoto S., Umemoto T., Wada H., et al. C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: implications for the destabilization of atherosclerotic plaque. Atherosclerosis 2008, 196:129-135.